Garlikov Julie 4
4 · NovaBay Pharmaceuticals, Inc. · Filed May 15, 2023
Insider Transaction Report
Form 4
Garlikov Julie
Director
Transactions
- Exercise/Conversion
Common Stock
2023-05-11+858→ 858 total - Exercise/Conversion
Restricted Stock Units
2023-05-11−858→ 0 total→ Common Stock (858 underlying)
Footnotes (2)
- [F1]On November 15, 2022, NovaBay Pharmaceuticals, Inc. effected a 1-for-35 reverse stock split of its common stock, which is reflected in the number of shares.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested on the one year anniversary of the date of grant.